We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CTPNV:EURONEXT AMSTERDAMCTP N.V. Analysis

Data as of 2026-05-27 - not real-time

€16.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CTP N.V. trades at €16.5, exactly at its identified resistance level, while comfortably sitting above the 20‑day (≈16.16) and 50‑day (≈16.08) moving averages, signaling short‑term bullish momentum. The MACD histogram is positive (0.04) and the RSI sits at 61, indicating room for upside without being overbought. Valuation metrics are compelling: a trailing P/E of 7.2 versus an industry average of 32.7, a price‑to‑book below 1 (0.92), and a dividend yield of 3.9% with a modest payout ratio of 26.6%, suggesting the dividend is sustainable. However, the stock shows a high 30‑day volatility of 25.6% and decreasing volume, which together with a low beta (0.16) point to a price that can swing sharply in a market of “Extreme Greed” sentiment.
On the fundamentals side, revenue grew 13.9% YoY to €1.0 bn, and margins remain robust (gross ~80%, operating ~67%). Yet, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio exceeding 108 and total debt of €9.4 bn dwarfing cash of €0.63 bn. Free cash flow is positive but modest (€64 m), and the max drawdown of -19% underscores downside risk. Overall, the stock appears undervalued and dividend‑rich, but the high leverage and liquidity constraints warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price at resistance with bullish MACD
  • High 30‑day volatility
  • Decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E and P/B ratios
  • Strong dividend yield and low payout ratio
  • Revenue growth above 10% YoY

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable dividend supported by cash flow
  • Elevated debt levels limiting upside
  • Cyclical exposure of real‑estate development sector

Key Metrics & Analysis

Financial Health

Revenue Growth13.90%
Profit Margin109.46%
P/E Ratio7.2
ROE13.49%
ROA2.18%
Debt/Equity108.35
P/B Ratio0.9
Op. Cash Flow€298.2M
Free Cash Flow€64.4M
Industry P/E32.7

Technical Analysis

TrendNeutral
RSI61.2
Support€15.60
Resistance€16.50
MA 20€16.16
MA 50€16.08
MA 200€18.01
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

GradeUndervalued
TypeBlend
Dividend Yield3.92%

Risk Assessment

Beta0.16
Volatility25.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.